Flowfect Discover™ - Accelerate cell therapy discovery, optimization, and development

Flowfect Tx™ - Expedite cell therapy development and manufacturing

Scalable Gene Delivery for More Lifesaving Wins for Reduced Time and Cost

BioCentriq Results of Study Designed to Test Transfection of T-cells Using Kytopen’s Flowfect® Technology

Delivery of mRNA and CRISPR-Cas9 RNP to primaryNatural Killer cells and T cells using Flowfect®,a new transfection technology

CRISPR-Cas9 RNP editing of primary T cells using the Flowfect® transfection technology platform

CRISPR-Cas9 RNP Editing of Primary T Cells Using the Flowfect® Transfection Technology Platform

Flowfect®: A scalable non-viral delivery process for T cell engineering

Flowfect® Transfection of iPSCs Maintains Cell Pluripotency

Microfluidic screening of electric fields for electroporation

Electro-mechanical transfection for non-viral primary immune cell engineering